1. Home
  2. SLNO vs MHO Comparison

SLNO vs MHO Comparison

Compare SLNO & MHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • MHO
  • Stock Information
  • Founded
  • SLNO 1999
  • MHO 1976
  • Country
  • SLNO United States
  • MHO United States
  • Employees
  • SLNO N/A
  • MHO N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • MHO Homebuilding
  • Sector
  • SLNO Health Care
  • MHO Consumer Discretionary
  • Exchange
  • SLNO Nasdaq
  • MHO Nasdaq
  • Market Cap
  • SLNO 3.7B
  • MHO 3.4B
  • IPO Year
  • SLNO 2014
  • MHO 1986
  • Fundamental
  • Price
  • SLNO $49.68
  • MHO $128.94
  • Analyst Decision
  • SLNO Strong Buy
  • MHO Strong Buy
  • Analyst Count
  • SLNO 9
  • MHO 2
  • Target Price
  • SLNO $114.89
  • MHO $153.00
  • AVG Volume (30 Days)
  • SLNO 2.3M
  • MHO 237.1K
  • Earning Date
  • SLNO 11-04-2025
  • MHO 10-22-2025
  • Dividend Yield
  • SLNO N/A
  • MHO N/A
  • EPS Growth
  • SLNO N/A
  • MHO N/A
  • EPS
  • SLNO N/A
  • MHO 17.05
  • Revenue
  • SLNO $98,675,000.00
  • MHO $4,475,753,000.00
  • Revenue This Year
  • SLNO N/A
  • MHO N/A
  • Revenue Next Year
  • SLNO $181.30
  • MHO N/A
  • P/E Ratio
  • SLNO N/A
  • MHO $7.56
  • Revenue Growth
  • SLNO N/A
  • MHO 4.77
  • 52 Week Low
  • SLNO $41.50
  • MHO $100.22
  • 52 Week High
  • SLNO $90.32
  • MHO $172.23
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 38.19
  • MHO 44.19
  • Support Level
  • SLNO $46.82
  • MHO $128.83
  • Resistance Level
  • SLNO $50.78
  • MHO $132.39
  • Average True Range (ATR)
  • SLNO 3.70
  • MHO 3.81
  • MACD
  • SLNO -1.37
  • MHO 0.70
  • Stochastic Oscillator
  • SLNO 25.56
  • MHO 65.81

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About MHO M/I Homes Inc.

M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions, and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprise a predominant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.

Share on Social Networks: